HL Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-35,840
| Closed | -$631K | – | 691 |
|
|
2017
Q3 | $631K | Buy |
35,840
+14,601
| +69% | +$257K | 0.01% | 439 |
|
|
2017
Q2 | $706K | Buy |
21,239
+5,516
| +35% | +$183K | 0.01% | 403 |
|
|
2017
Q1 | $505K | Sell |
15,723
-17
| -0.1% | -$546 | 0.01% | 453 |
|
|
2016
Q4 | $571K | Buy |
15,740
+9,601
| +156% | +$348K | 0.01% | 415 |
|
|
2016
Q3 | $282K | Sell |
6,139
-1,999
| -25% | -$91.8K | 0.01% | 546 |
|
|
2016
Q2 | $409K | Sell |
8,138
-518
| -6% | -$26K | 0.01% | 473 |
|
|
2016
Q1 | $463K | Buy |
8,656
+33
| +0.4% | +$1.77K | 0.01% | 446 |
|
|
2015
Q4 | $566K | Buy |
8,623
+1,540
| +22% | +$101K | 0.01% | 417 |
|
|
2015
Q3 | $400K | Buy |
7,083
+250
| +4% | +$14.1K | 0.01% | 469 |
|
|
2015
Q2 | $404K | Sell |
6,833
-172
| -2% | -$10.2K | 0.01% | 497 |
|
|
2015
Q1 | $436K | Sell |
7,005
-971
| -12% | -$60.4K | 0.01% | 491 |
|
|
2014
Q4 | $459K | Buy |
7,976
+773
| +11% | +$44.5K | 0.01% | 458 |
|
|
2014
Q3 | $387K | Buy |
7,203
+3
| +0% | +$161 | 0.01% | 468 |
|
|
2014
Q2 | $377K | Sell |
7,200
-9,390
| -57% | -$492K | 0.01% | 487 |
|
|
2014
Q1 | $877K | Sell |
16,590
-22,232
| -57% | -$1.18M | 0.03% | 284 |
|
|
2013
Q4 | $1.56M | Sell |
38,822
-65,876
| -63% | -$2.64M | 0.05% | 206 |
|
|
2013
Q3 | $3.96M | Sell |
104,698
-1,173
| -1% | -$44.3K | 0.14% | 96 |
|
|
2013
Q2 | $4.15M | Buy |
+105,871
| New | +$4.15M | 0.15% | 89 |
|